An interventional study of L-carnitine+Selenium in Hyperthyroidism, sponsored by Lo.Li.Pharma s.r.l. Completed at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-08.
Sponsored by Lo.Li.Pharma s.r.l · Not applicable, Interventional, and Treatment
The study aims to investigate the benefits of methimazole treatment in patients with hyperthyroidism, associated with supplementation of L-carnitine and Selenium.
112 studies on the registry are indexed under Hyperthyroidism; 27 are open to participants now.
This study's enrollment of 60 is close to the median of 60 across 61 interventional studies indexed under Hyperthyroidism.
Browse Hyperthyroidism studies →Lo.Li.Pharma s.r.l is the lead sponsor of 30 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients with hyperthyroidism under methimazole treatment
Patients with hyperthyroidism under methimazole treatment + supplementation with L-carnitine and Selenium
Dietary Supplement: L-carnitine+Selenium
Hyperthyroidism symptoms
Improvement of the patients' quality of life through questionnaire
Time frame: Change from baseline QoL at 6 months of supplementation
Hyperthyroidism symptoms
Improvement of the patients' quality of life through questionnaire
Time frame: Change from 6-months supplementation QoL at 12 months of intervention (end of study)
TRAb
Change in serum TRAb (TSH receptor antibodies)
Time frame: Four time points: baseline; after 3 months of supplementation; after 6 months of supplementation; end of the study (12 months)
TSH
Change in serum TSH (Thyroid stimulating hormone)
Time frame: Four time points: baseline; after 3 months of supplementation; after 6 months of supplementation; end of the study (12 months)
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Carnitine · Selenium